Trial Profile
Retrospective study of vedolizumab for the treatment of Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 25 Feb 2016 New trial record